VANGUARD SPECIALIZED FUNDS (CIK 734383) is an SEC-registered fund company with 7 reporting fund series and $281.4B in net assets as of 2026-04-30.
| Series | Net assets |
|---|---|
| VANGUARD DIVIDEND APPRECIATION INDEX FUND | $124.7B |
| VANGUARD REAL ESTATE INDEX FUND | $69.9B |
| VANGUARD DIVIDEND GROWTH FUND | $36.9B |
| VANGUARD HEALTH CARE FUND | $36.9B |
| VANGUARD ENERGY FUND | $7.6B |
| VANGUARD GLOBAL CAPITAL CYCLES FUND | $3.9B |
| VANGUARD GLOBAL ESG SELECT STOCK FUND | $1.5B |
| Holding | Value |
|---|---|
| Eli Lilly & Co | $3.3B |
| Merck & Co Inc | $2.0B |
| AstraZeneca PLC | $1.9B |
| UnitedHealth Group Inc | $1.4B |
| Johnson & Johnson | $1.3B |
| Edwards Lifesciences Corp | $1.2B |
| GSK PLC | $1.2B |
| Intuitive Surgical Inc | $1.0B |
| Boston Scientific Corp | $868.2M |
| Danaher Corp | $865.5M |
| CVS Health Corp | $812.6M |
| Argenx SE | $812.6M |
| Abbott Laboratories | $802.8M |
| Vertex Pharmaceuticals Inc | $770.1M |
| Cencora Inc | $765.2M |